Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1624399

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1624399

Global Cartilage Repair-Cartilage Regeneration Market Size By Application, By Treatment Modality, By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Single User License
USD 3950
Multi User License
USD 4850
Enterprise User License
USD 7550

Add to Cart

Cartilage Repair-Cartilage Regeneration Market Size And Forecast

Cartilage Repair-Cartilage Regeneration Market size was valued at USD 600.65 Million in 2019 and is projected to reachUSD 1535.69 Million by 2027, growing at aCAGR of 13.43% from 2020 to 2027.

The rising incidences of bone & joint disorders like osteoarthritis, the growing number of sports injuries, and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years. The Global Cartilage Repair-Cartilage Regeneration Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cartilage Repair-Cartilage Regeneration Market Definition

Cartilage Repair-Cartilage Regeneration Is a Joint Treatment for Having Healthy but Damaged Cartilage. the Cartilage Gets Damaged Due to Injury-Causing Impaired Function and Pain. a Direct Blow, Progressive Degeneration, and Traumatic Injury Are Some of The Reasons for Articular Cartilage Injuries. the Progressive Loss of Structure and Function of The Cartilage Causes Degeneration of Cartilage. Lack of Blood Supply Is One of The Reasons for Cartilage Damage.

Development of Osteoarthritis Can Be Prevented by Early Adoption of Cartilage Restoration or Regeneration Methods. Based on The Application, the Market Can Be Classified Into Hyaline Cartilage Repair and Regeneration and Fibrocartilage Repair and Regeneration. Various Types of Treatment Modalities Are Cell-Based Approaches, Chondrocyte Transplantation, Growth Factor Technology, Stem Cells, Non-Cell-Based Approaches, Tissue Scaffolds, and Cell-Free Composites.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cartilage Repair-Cartilage Regeneration Market Overview

The rising incidences of bone & joint disorders like osteoarthritis and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years. Also, the increasing geriatric population and the growing number of sports injuries expect a boost to the market in the coming years. Additionally, the growing prevalence of diabetes is predicted to fuel the market during the forecasted period. There are certain restraints and challenges faced which can hinder market growth. Factors such as unfavorable reimbursement scenarios and higher costs of therapy are likely to act as market restraints.

Global Cartilage Repair-Cartilage Regeneration Market: Segmentation Analysis

The Global Cartilage Repair-Cartilage Regeneration Market is Segmented on the basis of Application, Treatment Modality, And Geography.

Cartilage Repair-Cartilage Regeneration Market, By Application

  • Hyaline Cartilage Repair and Regeneration
  • Fibrocartilage Repair and Regeneration

Based on Application, the market is bifurcated into Hyaline Cartilage Repair and Regeneration and Fibrocartilage Repair and Regeneration. The Hyaline Cartilage Repair and Regeneration segment is expected to hold the largest market share. The factors can be attributed to the increasing incidents of physical trauma all over the world.

Cartilage Repair-Cartilage Regeneration Market, By Treatment Modality

  • Cell-Based Approaches
  • Chondrocyte Transplantation
  • Growth Factor Technology
  • Stem Cells
  • Non-Cell-Based Approaches
  • Tissue Scaffolds
  • Cell-Free Composites

Based on Treatment Modality, the market is bifurcated into Cell-Based Approaches, Chondrocyte Transplantation, Growth Factor Technology, Stem Cells, Non-Cell-Based Approaches, Tissue Scaffolds, and Cell-Free Composites. Cell-Based Approaches are predicted to hold the most significant CAGR in the forecasted period due to the technological advancements in stem cell-based therapies for cartilage repair and chondrocyte implantation products.

Cartilage Repair-Cartilage Regeneration Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on regional analysis, the Global Cartilage Repair-Cartilage Regeneration Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by the Asia Pacific owing to the rise in incidences of various disorders & injuries and the increasing geriatric population in this region.

Key Players

  • The "Global Cartilage Repair-Cartilage Regeneration Market " study report will provide valuable insight with an emphasis on the global market. The major players in the market Such As
  • Zimmer Biomet Holdings, Inc., DepuySynthes (Johnson & Johnson Company), Vericel Corporation, Smith & Nephew PLC, Osiris Therapeutics, Inc., Arthrex, Inc., RTI Surgical, ConmedLinvatec, Anika Therapeutics S. R. L., B. Braun Melsungen AG.
  • These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
Product Code: 24169

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY APPLICATION

  • 5.1 Overview
  • 5.2 Hyaline Cartilage Repair and Regeneration
  • 5.3 Fibrocartilage Repair and Regeneration

6 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY

  • 6.1 Overview
  • 6.2 Cell-Based Approaches
  • 6.3 Chondrocyte Transplantation
  • 6.4 Growth Factor Technology
  • 6.5 Stem Cells
  • 6.6 Non-Cell-Based Approaches
  • 6.7 Tissue Scaffolds
  • 6.8 Cell-Free Composites

7 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Zimmer Biomet Holdings, Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 DepuySynthes (Johnson & Johnson Company)
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Vericel Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Smith & Nephew PLC
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Osiris Therapeutics, Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Arthrex, Inc.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 RTI Surgical
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 ConmedLinvatec
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 LAnika Therapeutics S. R. L.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 B. Braun Melsungen AG
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!